BC
PRCT icon

Bridgefront Capital’s Procept Biorobotics PRCT Stock Holding History

Bridgefront Capital’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
+9,964
New +$249K 0.06% 431
2026
Q1 		– Sell
-7,326
Closed -$230K – 715
2025
Q4 		$230K Buy
7,326
+843
+13% +$28K 0.06% 431
2025
Q3 		$231K Buy
+6,483
New +$296K 0.07% 479

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bridgefront Capital's PRCT Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 9,964 shares worth $225K. The stake represents 0.06% of the portfolio and ranks #431 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in PRCT as recently as Q4 2025.

Bridgefront Capital first reported a position in PRCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $231K in Q3 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Bridgefront Capital held 9,964 shares of Procept Biorobotics worth $225K as of Q2 2026.
  • Procept Biorobotics was a new Bridgefront Capital position in Q2 2026.
  • Procept Biorobotics made up 0.06% of Bridgefront Capital's portfolio in Q2 2026, its #431 holding.
  • Bridgefront Capital first reported a position in Procept Biorobotics in Q3 2025 and has held it in 3 quarters since.
  • Bridgefront Capital's Procept Biorobotics position peaked at $231K in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.